Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
lenvatinib
×
Thoracic
×
Clear all
Filters
3
NCT03829332
2026-02-19
LEAP-007
Merck Sharp & Dohme LLC
Phase 3
Completed
623 enrolled
26 charts
NCT03976375
2025-08-15
LEAP-008
Merck Sharp & Dohme LLC
Phase 3
Completed
422 enrolled
30 charts
NCT04676412
2025-04-04
LEAP-007
Merck Sharp & Dohme LLC
Phase 3
Completed
107 enrolled
24 charts